<DOC>
	<DOCNO>NCT00776347</DOCNO>
	<brief_summary>The purpose study evaluate change cerebral glucose metabolism donepezil therapy associate change glucose metabolism symptom .</brief_summary>
	<brief_title>Donepezil Therapy Changes Symptoms Glucose Metabolism Patients With Dementia With Lewy Bodies ( DLB )</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Lewy Body Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>DLB patient : fulfill diagnostic criterion DLB 60 85 year old righthanded Clinical Dementia Rating ( CDR ) â‰§ 0.5 Mini Mental State Examination ( MMSE ) score 10 26 Normal Controls : independent subjective objective cognitive impairment 60 85 year old righthanded MMSE score 24 DLB patient : diabetes mellitus pathological change MRI brain atrophy complication history dementia DLB , psychiatric disease , physical disorder affect brain function severe complication cardiovascular , hepatic , renal , diseases unable secure safety severe digestive ulcus severe bronchitic asthma obstructive lung disease caregiver know patient 's condition well Normal Controls : diabetes mellitus take donepezil abnormal finding MRI complication history brain injury , psychiatric disease , physical disorder affect brain function</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Dementia Lewy body ( DLB )</keyword>
	<keyword>FDG-PET</keyword>
</DOC>